Transaction · 0001159036-26-000133

Posard Matthew L.

Posard Matthew L., DIR, reported an open-market or private sale at HALOZYME THERAPEUTICS, INC. involving 3300.000000 shares for an estimated $357898.20. Reported holdings after the transaction were 54809.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SDIR
HALOHALOZYME THERAPEUTICS, INC.
Filing timeOct 02
Trade dateOct 01, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position traded5.68%Shares sold ÷ (holdings after + shares sold). Estimated position before: 58,109 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$109.86
Pre-filing
1mo ago -1.9%1w ago +4.9%1d ago +0.5%
Returns since
7d30d90d180d1y

HALO price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
HALO since 2026-10-02Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001159036-26-000133
Common Stock
Transaction date
Oct 01, 2026
Filed Oct 02, 2026, 08:38 PM · 1d delay
Shares
3.30k sh
$108.45 per share
Estimated value
-$357k
Computed from shares × price
Holdings after
54.8k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership Repeat Seller 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on June 15, 2026 in accordance with Rule 10b5-1.

  2. F2

    Represents a weighted average sales price per share. The shares were sold at prices ranging from $106.930 to $107.660. The Reporting Person has provided to the issuer, and will provide to any

  3. (3 footnotes)

    security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

  4. F3

    Represents a weighted average sales price per share. The shares were sold at prices ranging from $107.990 to $108.930. The Reporting Person has provided to the issuer, and will provide to any

  5. F4

    Represents a weighted average sales price per share. The shares were sold at prices ranging from $109.040 to $109.970. The Reporting Person has provided to the issuer, and will provide to any

Original filing · 0001159036-26-000133
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

HALO